Passage of ureteral concretions. A clinical and experimental study on the role of different therapeutic methods and urinary tract infection on the passage of ureteral concretions.
D000628:Aminophylline / Q000627:therapeutic use; D000818:Animals; D000892:Anti-Infective Agents, Urinary / Q000627:therapeutic use; D003558:Cystoscopy; D004231:Diuresis / Q000187:drug effects; D005260:Female; D005665:Furosemide / Q000627:therapeutic use; D006801:Humans; D008297:Male; D009392:Nephrectomy; D010113:Oxyphenbutazone / Q000627:therapeutic use; D010208:Papaverine / Q000008:administration & dosage / Q000627:therapeutic use; D010880:Piperidines / Q000627:therapeutic use; D010919:Placebos; D013806:Theophylline / Q000627:therapeutic use; D014514:Ureteral Calculi / Q000150:complications / Q000188:drug therapy / Q000601:surgery / Q000628:therapy*; D014515:Ureteral Diseases / Q000382:microbiology; D014552:Urinary Tract Infections / Q000188:drug therapy; D014556:Urine / Q000382:microbiology; D014567:Urography
D000892:Anti-Infective Agents, Urinary; D010880:Piperidines; D010919:Placebos; D000628:Aminophylline; D005665:Furosemide; D013806:Theophylline; D010208:Papaverine; D010113:Oxyphenbutazone